Primary Progressive Multiple Sclerosis Treatment Market Rising Disease Awareness and Innovation Drive Growth Beyond US$ 3.2 Billion
The global Primary Progressive Multiple Sclerosis (PPMS) Treatment Market is poised for substantial expansion over the coming decade, supported by increasing disease prevalence, growing healthcare investments, and continuous advancements in neurological drug development. Valued at US$ 828.4 Mn in 2021, the market is projected to grow at a CAGR of 14.7% between 2022 and 2031, reaching more than...
0 Comments 0 Shares 5 Views 0 Reviews